Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Archive
Global health
Authors
About
Help
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Archive
Global health
Authors
About
Help
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 13, Issue 9
Use of rituximab in lymphomatoid granulomatosis with isolated central nervous system involvement
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Rare disease
Case report
Use of rituximab in lymphomatoid granulomatosis with isolated central nervous system involvement
Online download statistics by month:
Online download statistics by month: September 2020 to November 2021
Abstract
Full
Pdf
Sep 2020
569
13
9
Oct 2020
441
6
6
Nov 2020
214
5
5
Dec 2020
133
10
3
Jan 2021
82
8
7
Feb 2021
61
2
1
Mar 2021
91
2
1
Apr 2021
88
2
9
May 2021
22
1
1
Jun 2021
3
3
3
Jul 2021
3
1
2
Aug 2021
3
3
1
Oct 2021
54
1
0
Nov 2021
42
2
1
Total
1806
59
49
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF